Marta Ribeiro,  —

Marta graduated from Universidade Fernando Pessoa in Porto with a degree in Communication Sciences and a Masters degree in New Communication Technologies. She has experience in social media, worked with several media channels, and has also worked as a freelance photographer and a graphic artist for almost 10 years.

Articles by Marta Ribeiro

Developing a Research Model For IPF

LabTV shared this video in late 2015, where you can meet Abdo Durra- a research assistant in the Gomperts Lab at UCLA. Durra wants to understand and treat lung diseases, his main purpose being to develop a research model for IPF. Learn more about pulmonary fibrosis: http://bit.ly/1VElTQA…

7 Pulmonary Fibrosis Headlines

1. 6 Non-Pharmacological Pulmonary Fibrosis Treatments According to PulmonaryFibrosis.org, there are several types of treatment options to help you with your pulmonary fibrosis. In this article, we’re focusing on bringing you non-pharmacological pulmonary fibrosis treatments. Read more about it: http://bit.ly/1SgrR74 2. …

7 Common Pulmonary Fibrosis Symptoms

Anyone can suffer from pulmonary fibrosis, but it’s more common among middle-aged and older adults. Each patient has an individualized experience with the disease, which means that it can progress faster in some patients than others. As the lung tissue becomes thicker, the lungs lose their ability to properly…

Pulmonary Fibrosis: Respiratory Muscle Exercises

In this video from ManagingSOB, it is discussed how to strengthen the respiratory muscles with respiratory muscle exercises. Learn more about pulmonary fibrosis: http://bit.ly/1VElTQA Pulmonary Fibrosis News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis…

Experimental PF Therapy Granted U.S. Patent Allowance

Galectin Therapeutics, Inc., announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its patent application “Method for Treatment of Pulmonary Fibrosis” — number 13/999,389 — on its lead compound GR-MD-02. Galectin Therapeutics is currently developing carbohydrate-based therapies…

How to Treat Pulmonary Fibrosis

There is currently no cure for pulmonary fibrosis and patients often face a prognosis of three to five years after diagnosis. However, medication and other treatment options can help improve patients’ quality of life. Medication for the treatment of patient with pulmonary fibrosis Nintedanib…